文献速递重症综合管理与镇静镇痛

衰弱对持续性危重症的影响:一项基于人群的队列研究

Impact of frailty on persistent critical illness: a population-based cohort study.
PubMed 文献 · Intensive Care Med · 2022-02-04
一句话结论在澳大利亚和新西兰168个ICU的269785例成人中,衰弱(CFS≥5)患者发生持续性危重症(PerCI)的比例为4.3% vs 3%,PerCI患者院内死亡30.5% vs 18%;随ICU住院时间延长,衰弱对死亡预测的增益从第1天AUROC提高0.1%升至第17天3.6%。

该研究为前瞻性两国队列研究的二次分析,纳入澳大利亚和新西兰168个ICU的269785例危重症成人,用临床衰弱量表(CFS≥5为衰弱)评估衰弱是否改变持续性危重症(PerCI)的发生时点、发生风险及后续院内死亡。结果:衰弱患者2190/50814(4.3%)发生PerCI,无衰弱(CFS≤4)患者6624/218971(3%)发生PerCI(P<0.001);PerCI患者中衰弱者669/2190(30.5%)院内死亡,无衰弱者1194/6624(18%)院内死亡(P<0.001)。定义PerCI发生的时间点不随衰弱程度变化,但随ICU住院时间延长,纳入衰弱对死亡判别力的改善逐步增加(ICU第1天AUROC提高0.1%,第17天提高3.6%)。作者认为,未来工作应探索将衰弱纳入预后模型,尤其是长期住院患者。

要点

  • 衰弱(CFS≥5)患者PerCI发生率为4.3%(2190/50814),高于无衰弱(CFS≤4)患者的3%(6624/218971),P<0.001。
  • PerCI患者中,衰弱者院内死亡30.5%(669/2190),无衰弱者18%(1194/6624),P<0.001。
  • 定义PerCI发生的时间点不随衰弱程度变化。
  • 随ICU住院时间延长,衰弱对死亡判别力的改善从第1天AUROC提高0.1%增至第17天3.6%。
  • 作者认为未来应探索将衰弱纳入预后模型,尤其针对长期住院患者。

适用人群与场景

  • 澳大利亚和新西兰168个ICU的269785例危重症成人,为前瞻性两国队列研究的二次分析。
  • 按临床衰弱量表(CFS)分为衰弱组(CFS≥5)与无衰弱组(CFS≤4)。

诊断标准与关键阈值

  • 衰弱定义:临床衰弱量表(CFS)≥5分;无衰弱定义:CFS≤4分。
  • 持续性危重症(PerCI)发生时间点不随衰弱程度变化。

研究设计与关键结果

  • 研究类型:前瞻性两国队列研究的二次分析;样本量269785例危重症成人,来自澳大利亚和新西兰168个ICU。
  • PerCI发生率:衰弱组(CFS≥5)2190/50814(4.3%) vs 无衰弱组(CFS≤4)6624/218971(3%),P<0.001。
  • PerCI患者院内死亡:衰弱组669/2190(30.5%) vs 无衰弱组1194/6624(18%),P<0.001。
  • 定义PerCI发生的时间点不随衰弱程度变化。
  • 随ICU住院时间延长,纳入衰弱对死亡判别力的改善逐步增加:ICU第1天AUROC提高0.1%,第17天提高3.6%。

证据类型、等级与局限

  • 证据类型:前瞻性两国队列研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来工作应探索将衰弱纳入预后模型,尤其是长期住院患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Acute illness severity predicts mortality in intensive care unit (ICU) patients, however, its predictive value decreases over time in ICU. Typically after 10 days, pre-ICU (antecedent) characteristics become more predictive of mortality, defining the onset of persistent critical illness (PerCI). How patient frailty affects development and death from PerCI is unknown.

METHODS: We conducted a secondary analysis of data from a prospective binational cohort study including 269,785 critically ill adults from 168 ICUs in Australia and New Zealand, investigating whether frailty measured with the Clinical Frailty Scale (CFS) changes the timing of onset and risk of developing PerCI and of subsequent in-hospital mortality. We assessed associations between frailty (CFS ≥ 5) and mortality prediction using logistic regression and area under the receiver operating characteristics (AUROC) curves.

RESULTS: 2190 of 50,814 (4.3%) patients with frailty (CFS ≥ 5) versus 6624 of 218,971 (3%) patients without frailty (CFS ≤ 4) developed PerCI (P < 0.001). Among patients with PerCI, 669 of 2190 (30.5%) with frailty and 1194 of 6624 without frailty (18%) died in hospital (P < 0.001). The time point defining PerCI onset did not vary with frailty degree; however, with increasing length of ICU stay, inclusion of frailty progressively improved mortality discrimination (0.1% AUROC improvement on ICU day one versus 3.6% on ICU day 17).

CONCLUSION: Compared to patients without frailty, those with frailty have a higher chance of developing and dying from PerCI. Moreover the importance of frailty as a predictor of mortality increases with ICU length of stay. Future work should explore incorporation of frailty in prognostic models, particularly for long-staying patients.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Darvall JN, Bellomo R, Bailey M, et al. Impact of frailty on persistent critical illness: a population-based cohort study. Intensive Care Med. 2022. PMID: 35119497. doi:10.1007/s00134-022-06617-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。